[Simple and safe treatment offers new perspectives].
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D006801:Humans; D007279:Injections, Subcutaneous; D008134:Long-Term Care; D011565:Psoriasis / Q000188:drug therapy* / Q000276:immunology / Q000451:nursing*; D013601:T-Lymphocytes / Q000187:drug effects
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C472181:efalizumab